$140 Million Verdict in AndroGel Testosterone Case
A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking testosterone-replacement drug AndroGel.
October 09, 2017 at 05:24 PM
5 minute read
Northern District of Illinois at Dirksen Federal Building (foreground) in downtown Chicago. |
A federal jury in Chicago has ordered the pharmaceutical company AbbVie Inc. to pay a Tennessee man more than $140 million as compensation for a heart attack he claimed was caused by his taking the testosterone-replacement drug AndroGel.
The Oct. 5 verdict, first reported by Reuters, was delivered after a mistrial was declared in June when one of plaintiff Jeffrey Konrad's lead attorneys became ill.
The pharmaceutical company said it planned to appeal. Another of Konrad's lawyers, David Buchanan of the New York office of Seeger Weiss, could not be reached for comment Monday.
Konrad's lawsuit, filed in 2015, is one of about 6,000 similar cases pending against the Lake Bluff, Illinois-based AbbVie before U.S. District Judge Matthew Kennelly of the Northern District of Illinois.
The verdict included $140 million in punitive damages and $140,000 in compensatory damages, according to the judgment.
Plaintiffs are alleging that AndroGel can cause heart attacks, strokes and other injuries.
AbbVie has said that its marketing of AndroGel adhered strictly to uses approved by the Food and Drug Administration, and that it was in full compliance with applicable standards.
Konrad, 56, had been using AndroGel for two months in 2010 when he suffered a heart attack. He has since recovered from his injuries, according to the lawsuit.
The company contended in court papers that Konrad's heart attack was caused by other factors, such as obesity and high blood pressure. AbbVie also said it made no misrepresentations about AndroGel's safety.
AbbVie's AndroGel is one of the dominant testosterone treatments on the market, with sales of $675 million in 2016, Reuters reported.
AbbVie was created in 2013 as an offshoot of Abbott Laboratories.
Contact the reporter at [email protected].
Northern District of Illinois at Dirksen Federal Building (foreground) in downtown Chicago. |
A federal jury in Chicago has ordered the pharmaceutical company
The Oct. 5 verdict, first reported by Reuters, was delivered after a mistrial was declared in June when one of plaintiff Jeffrey Konrad's lead attorneys became ill.
The pharmaceutical company said it planned to appeal. Another of Konrad's lawyers, David Buchanan of the
Konrad's lawsuit, filed in 2015, is one of about 6,000 similar cases pending against the Lake Bluff, Illinois-based AbbVie before U.S. District Judge Matthew Kennelly of the Northern District of Illinois.
The verdict included $140 million in punitive damages and $140,000 in compensatory damages, according to the judgment.
Plaintiffs are alleging that AndroGel can cause heart attacks, strokes and other injuries.
AbbVie has said that its marketing of AndroGel adhered strictly to uses approved by the Food and Drug Administration, and that it was in full compliance with applicable standards.
Konrad, 56, had been using AndroGel for two months in 2010 when he suffered a heart attack. He has since recovered from his injuries, according to the lawsuit.
The company contended in court papers that Konrad's heart attack was caused by other factors, such as obesity and high blood pressure. AbbVie also said it made no misrepresentations about AndroGel's safety.
AbbVie's AndroGel is one of the dominant testosterone treatments on the market, with sales of $675 million in 2016, Reuters reported.
AbbVie was created in 2013 as an offshoot of
Contact the reporter at [email protected].
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
Read the Document: 'Google Must Divest Chrome,' DOJ Says, Proposing Remedies in Search Monopoly Case
3 minute read
Amir Ali, MacArthur Justice Center Director, Confirmed to DC District Court
Health Care Giants Sue FTC, Allege Lina Khan Using Loaded Process to Vilify Pharmacy Benefit Managers
3 minute readTrending Stories
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
